Compounds > technetium tc 99m-imidodiphosphate
Page last updated: 2024-12-08

technetium tc 99m-imidodiphosphate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

technetium Tc 99m-imidodiphosphate: tracer of infarct-avid imaging [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID163105
MeSH IDM0107520

Synonyms (8)

Synonym
technetium tc 99m-imidodiphosphate
66142-88-9
tc-99m-iminodiphosphonate
tc-99m-idp
technetium imidodiphosphate
tc-99m-imidodiphosphate
imidodiphosphoric acid, technetium salt
dioxidophosphinimyl phosphate;technetium(4+)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (33.33)18.7374
1990's6 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.31

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.31 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.62 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.31)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies4 (44.44%)4.05%
Observational0 (0.00%)0.25%
Other5 (55.56%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
technetium
Technetium: The first artificially produced element and a radioactive fission product of URANIUM. Technetium has the atomic symbol Tc, and atomic number 43. All technetium isotopes are radioactive. Technetium 99m (m=metastable) which is the decay product of Molybdenum 99, has a half-life of about 6 hours and is used diagnostically as a radioactive imaging agent. Technetium 99 which is a decay product of technetium 99m, has a half-life of 210,000 years.		2.6530manganese group element atom
ConditionIndicatedRelationship StrengthStudiesTrials
Cardiovascular Stroke
[description not available]		01.9610
Myocardial Infarction
NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).		01.9610
Complication, Postoperative
[description not available]		01.9810
Low Back Ache
[description not available]		01.9810
Postoperative Complications
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery.		01.9810
Low Back Pain
Acute or chronic pain in the lumbar or sacral regions, which may be associated with musculo-ligamentous SPRAINS AND STRAINS; INTERVERTEBRAL DISK DISPLACEMENT; and other conditions.		01.9810
Empyema, Gall Bladder
[description not available]		01.9810
Bile Duct Obstruction, Intrahepatic
[description not available]		01.9810
Acute Disease
Disease having a short and relatively severe course.		01.9810
Cholecystitis
Inflammation of the GALLBLADDER; generally caused by impairment of BILE flow, GALLSTONES in the BILIARY TRACT, infections, or other diseases.		01.9810
Cholestasis, Intrahepatic
Impairment of bile flow due to injury to the HEPATOCYTES; BILE CANALICULI; or the intrahepatic bile ducts (BILE DUCTS, INTRAHEPATIC).		01.9810
Bone Loss, Osteoclastic
[description not available]		01.9710
Age-Related Osteoporosis
[description not available]		01.9710
Osteoporosis
Reduction of bone mass without alteration in the composition of bone, leading to fractures. Primary osteoporosis can be of two major types: postmenopausal osteoporosis (OSTEOPOROSIS, POSTMENOPAUSAL) and age-related or senile osteoporosis.		01.9710
Tracheitis
INFLAMMATION of the TRACHEA that is usually associated with RESPIRATORY TRACT INFECTIONS.		01.9710
Bronchitis
Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI.		01.9710
Anemia, Hemolytic, Acquired
[description not available]		01.9710
Bone Cancer
[description not available]		01.9710
Anemia, Hemolytic
A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).		01.9710
Bone Neoplasms
Tumors or cancer located in bone tissue or specific BONES.		01.9710
Polyarthritis
[description not available]		01.9610
Arthritides, Bacterial
[description not available]		01.9610
Arthritis
Acute or chronic inflammation of JOINTS.		01.9610
Gout
Metabolic disorder characterized by recurrent acute arthritis, hyperuricemia and deposition of sodium urate in and around the joints, sometimes with formation of URIC ACID calculi.		01.9610